CD33 and neoplasm: Among the myeloid cells, MDSC inhibit tumor immunity by being mobilized from myeloid to peripheral tissues, and they can be marked by CD33 or arginase1 (ARG1), while all the cells marked by them did not strictly represent MDSC [40].